Table 1 The basic information of 126 patients with HCC.
From: ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma
Clinicopathological features | Number | Low expression, N (%) | High expression, N (%) | P value |
|---|---|---|---|---|
Age | ||||
 <60 | 69 | 49 (71.0) | 20 (29.0) | 0.66 |
 ≥60 | 57 | 44 (77.2) | 13 (22.8) |  |
Gender | ||||
 Male | 103 | 74 (71.8) | 29 (28.2) | 0.288 |
 Female | 23 | 19 (82.6) | 4 (17.4) |  |
Tumor size | ||||
 ≤5 cm | 66 | 46 (69.7) | 20 (30.3) | 0.314 |
 >5 cm | 60 | 47 (78.3) | 13 (21.7) |  |
Edmondson’s grade | ||||
 I–II | 37 | 18 (48.6) | 19 (51.4) | 0.274 |
 III–V | 89 | 75 (84.3) | 14 (15.7) |  |
Cirrhosis | ||||
 Negative | 65 | 55 (84.6) | 10(15.4) | 0.005* |
 Positive | 61 | 38 (62.3) | 23(37.7) |  |
AFP(ng/ml) | ||||
 ≤20 | 49 | 41(83.7) | 8 (16.3) | 0.045* |
 >20 | 77 | 52 (67.5) | 25 (32.5) |  |
HBV | ||||
 Negative | 13 | 9 (69.2) | 4 (30.8) | 0.683 |
 Positive | 110 | 82 (74.5) | 28 (25.4) |  |
HCV | 3 | 2 (66.7) | 1 (33.3) | Â |
Intrahepatic metastasis | ||||
 Negative | 114 | 83 (72.8) | 31 (27.2) | 0.434 |
 Positive | 12 | 10 (83.3) | 2 (16.7) |  |
